RSS
Rosenblum Silverman Sutton Portfolio holdings
AUM
$413M
This Quarter Return
+14.37%
1 Year Return
+23.28%
3 Year Return
+154.39%
5 Year Return
+196.94%
10 Year Return
–
AUM
$236M
AUM Growth
+$236M
(+12%)
Cap. Flow
+$369K
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
39.67%
Holding
68
New
5
Increased
16
Reduced
36
Closed
5
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$3.87M |
| 2 |
Celanese
CE
|
$3.04M |
| 3 |
Citizens Financial Group
CFG
|
$2.21M |
| 4 |
Atkore
ATKR
|
$2.01M |
| 5 |
ON Semiconductor
ON
|
$1.87M |
Top Sells
| 1 |
American International
AIG
|
$4.27M |
| 2 |
Gilead Sciences
GILD
|
$3.17M |
| 3 |
NVIDIA
NVDA
|
$1.4M |
| 4 |
WOOF
VCA Inc.
WOOF
|
$1.12M |
| 5 |
American Tower
AMT
|
$627K |
Sector Composition
| 1 | Technology | 25.54% |
| 2 | Consumer Discretionary | 14.93% |
| 3 | Healthcare | 14.2% |
| 4 | Communication Services | 13.49% |
| 5 | Financials | 12.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aclaris Therapeutics
ACRS
$221M
| $977K | 0.41% |
32,750
+11,600
| +55% | +$346K |
|
52
Morgan Stanley
MS
$236B
| $973K | 0.41% |
22,707
-950
| -4% | -$40.7K |
|
53
RTX Corp
RTX
$211B
| $829K | 0.35% |
7,385
+3,285
| +80% | +$369K |
|
54
Brunswick
BC
$4.13B
| $693K | 0.29% |
11,330
+3,120
| +38% | +$191K |
|
|
55
Gilead Sciences
GILD
$139B
| $675K | 0.29% |
9,945
-46,641
| -82% | -$3.17M |
|
56
DexCom
DXCM
$29.1B
| $668K | 0.28% |
7,881
-750
| -9% | -$63.6K |
|
57
S&P Global
SPGI
$164B
| $586K | 0.25% |
4,479
| – | – |
|
58
Comfort Systems
FIX
$24.3B
| $425K | 0.18% |
11,600
| – | – |
|
|
EGRX
59
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $354K | 0.15% |
4,265
-25
| -0.6% | -$2.08K |
|
60
Berkshire Hathaway Class B
BRK.B
$1.08T
| $297K | 0.13% |
+1,780
| New | +$297K |
|
61
3M
MMM
$81.9B
| $271K | 0.11% |
1,415
-100
| -7% | -$19.2K |
|
|
GTT
62
DELISTED
GTT Communications, Inc.
GTT
| $258K | 0.11% |
10,600
| – | – |
|
|
63
American International
AIG
$44.6B
| – | – |
-65,302
| Closed | -$4.27M |
|
64
Bristol-Myers Squibb
BMY
$95.8B
| – | – |
-8,885
| Closed | -$519K |
|
|
LDL
65
DELISTED
Lydall, Inc.
LDL
| – | – |
-5,000
| Closed | -$309K |
|
|
JCP
66
DELISTED
J.C. Penney Company, Inc.
JCP
| – | – |
-53,750
| Closed | -$447K |
|
|
TSRO
67
DELISTED
TESARO, Inc.
TSRO
| – | – |
-2,080
| Closed | -$280K |
|